Cempra to Report Fourth Quarter and Full Year 2015 Financial Results
17 févr. 2016 07h30 HE
|
Melinta Therapeutics, Inc.
CHAPEL HILL, N.C., Feb. 17, 2016 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics in the face of rising antibiotic...
Cempra to Present Solithromycin Data at ID Week 2015
05 oct. 2015 07h30 HE
|
Melinta Therapeutics, Inc.
CHAPEL HILL, N.C., Oct. 5, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
Cempra to Present Solithromycin Data in COPD Patient Subgroup at European Respiratory Society International Congress
24 sept. 2015 07h30 HE
|
Melinta Therapeutics, Inc.
CHAPEL HILL, N.C., Sept. 24, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
Cempra to Present at Three Upcoming Investor Conferences
03 sept. 2015 07h30 HE
|
Melinta Therapeutics, Inc.
CHAPEL HILL, N.C., Sept. 3, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
Cempra to Present at the Wedbush PacGrow 2015 Healthcare Conference
04 août 2015 07h30 HE
|
Melinta Therapeutics, Inc.
CHAPEL HILL, N.C., Aug. 4, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
Cempra Reports Second Quarter 2015 Financial Results and Provides Corporate Update
29 juil. 2015 16h04 HE
|
Melinta Therapeutics, Inc.
CHAPEL HILL, N.C., July 29, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
Cempra to Report Second Quarter 2015 Financial Results
22 juil. 2015 07h30 HE
|
Melinta Therapeutics, Inc.
CHAPEL HILL, N.C., July 22, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
Cempra Completes Patient Enrollment of Solitaire-IV Phase 3 Clinical Trial
07 juil. 2015 07h00 HE
|
Melinta Therapeutics, Inc.
CHAPEL HILL, N.C., July 7, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...